Analysts at Zacks Research increased their FY2025 EPS estimates for Diamondback Energy in a note issued to investors on ...
Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for Entergy in a research report issued to clients ...
4h
Zacks Investment Research on MSNACM Research, Inc. (ACMR) is Attracting Investor Attention: Here is What You Should KnowACM Research, Inc. (ACMR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Gogo Inc. (GOGO) on Friday reported a loss of $28.2 million in its fourth quarter. On a per-share basis, the Broomfield, Colorado-based company ...
MORTON GROVE, Ill. (AP) — MORTON GROVE, Ill. (AP) — Lifeway Foods Inc. (LWAY) on Friday reported a loss of $160,000 in its fourth quarter. On a per-share basis, the Morton Grove, Illinois-based ...
2h
Zacks.com on MSNPaycom (PAYC) Down 4.3% Since Last Earnings Report: Can It Rebound?Paycom (PAYC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.
HOUSTON (AP) — HOUSTON (AP) — Crown Castle International Corp. (CCI) on Thursday reported a key measure of profitability in its fourth quarter. The results missed Wall Street expectations. The real ...
(TOUR) on Friday reported a loss of $3.3 million in its fourth quarter. The Nanjing, China-based company said it had a loss of 3 cents per share.
SOUTH SAN FRANCISCO, Calif. (AP) — ...
1h
Zacks Investment Research on MSNStitch Fix (SFIX) Upgraded to Buy: Here's WhyStitch Fix (SFIX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...
19h
Zacks.com on MSNViking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to NoteIn the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $29.73, denoting a +0.61% change from the preceding trading day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results